Her medical history was notable for chronic myelomonocytic leukemia, diagnosed 6 years previously and managed expectantly by monitoring the patient's complete blood count. Over several months ...

Nat Clin Pract Gastroenterol Hepatol. 2007;4(4):229-233.

Andrew Kuykendall, MD, discusses the background, methods, and design of a phase 2 study which evaluated fedratinib.

Hany Elmariah, MD, discussed the safety profile of fedratinib and its evolving role in the post-transplant setting for patients with myeloproliferative neoplasms.

Leukemia is classified by stage. Different types of leukemia (acute vs. chronic) have different staging systems—with some with as few as three stages and others with as many as seven—but each ...

Driving instructor Michael Kyriacos Efstratiou from Winchmore Hill was diagnosed with chronic myelomonocytic leukaemia (CMML) just before Christmas. His daughter, Ellianna Efstratiou ...

The biotech has ambitions however to expand the use of the drug to other diseases that involve CD123, which include chronic myelomonocytic leukaemia (CMML), myelofibrosis and acute myeloid ...

Chronic myeloid (or myelogenous) leukaemia (CML), also known as chronic granulocytic leukaemia, is a cancer of the white blood cells. It is characterized by the increased and unregulated growth of ...

(RTTNews) - Salarius Pharmaceuticals, Inc. (SLRX), a clinical-stage biopharmaceutical company, on Monday announced the resumption of patient enrollment in the investigator-initiated Phase 1/2 ...